Process View
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a low-density lipoprotein particle stimulus.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "response to low density lipoprotein particle"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| PPARGC1A | peroxisome proliferator-activated receptor gamma, coactivator 1 alpha | 0.992 | ||
| HNF4A | hepatocyte nuclear factor 4, alpha | 0.976 | ||
| RXRA | retinoid X receptor, alpha | 0.960 | ||
| PLAU | plasminogen activator, urokinase | 0.951 | ||
| CTNNB1 | catenin (cadherin-associated protein), beta 1, 88kDa | 0.905 | ||
| CTNND1 | catenin (cadherin-associated protein), delta 1 | 0.832 | ||
| DSG2 | desmoglein 2 | 0.731 | ||
| CTNNA1 | catenin (cadherin-associated protein), alpha 1, 102kDa | 0.594 | ||
| MED15 | mediator complex subunit 15 | 0.423 | ||
| JUP | junction plakoglobin | 0.421 | ||
| CREBBP | CREB binding protein | 0.396 | ||
| CDH1 | cadherin 1, type 1, E-cadherin (epithelial) | 0.318 | Human | |
| AR | androgen receptor | 0.258 | ||
| HR | hairless homolog (mouse) | 0.175 | ||
| RUNX1 | runt-related transcription factor 1 | 0.169 | ||
| CDH3 | cadherin 3, type 1, P-cadherin (placental) | 0.145 | Human | |
| PTPRJ | protein tyrosine phosphatase, receptor type, J | 0.142 | ||
| STX12 | syntaxin 12 | 0.137 | ||
| PLAT | plasminogen activator, tissue | 0.128 | ||
| NCOR2 | nuclear receptor corepressor 2 | 0.117 | ||
| SREBF2 | sterol regulatory element binding transcription factor 2 | 0.097 | ||
| PPARA | peroxisome proliferator-activated receptor alpha | 0.093 | Human | |
| NCOR1 | nuclear receptor corepressor 1 | 0.092 | ||
| CHD9 | chromodomain helicase DNA binding protein 9 | 0.089 | ||
| HIPK2 | homeodomain interacting protein kinase 2 | 0.088 | ||
| TCF7L2 | transcription factor 7-like 2 (T-cell specific, HMG-box) | 0.083 | ||
| DSP | desmoplakin | 0.075 | ||
| GLIS2 | GLIS family zinc finger 2 | 0.058 | ||
| NCOA6 | nuclear receptor coactivator 6 | 0.054 | ||
| SCD | stearoyl-CoA desaturase (delta-9-desaturase) | 0.053 | ||
| ESRRG | estrogen-related receptor gamma | 0.052 | ||
| LDLR | low density lipoprotein receptor | 0.051 | ||
| CFTR | cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) | 0.046 | ||
| TGM2 | transglutaminase 2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase) | 0.045 | ||
| BTRC | beta-transducin repeat containing | 0.044 | ||
| PLAUR | plasminogen activator, urokinase receptor | 0.043 | ||
| INSIG1 | insulin induced gene 1 | 0.041 | ||
| CTNNBIP1 | catenin, beta interacting protein 1 | 0.041 | ||
| PPARG | peroxisome proliferator-activated receptor gamma | 0.040 | ||
| ORM1 | orosomucoid 1 | 0.040 | ||
| RARA | retinoic acid receptor, alpha | 0.038 | ||
| NCOA1 | nuclear receptor coactivator 1 | 0.038 | ||
| SP1 | Sp1 transcription factor | 0.037 | ||
| SMAD3 | SMAD family member 3 | 0.035 | ||
| TRIM11 | tripartite motif containing 11 | 0.033 | ||
| PKP1 | plakophilin 1 (ectodermal dysplasia/skin fragility syndrome) | 0.030 | ||
| PKP3 | plakophilin 3 | 0.030 | ||
| ITGA5 | integrin, alpha 5 (fibronectin receptor, alpha polypeptide) | 0.029 | ||
| CDH11 | cadherin 11, type 2, OB-cadherin (osteoblast) | 0.029 | ||
| TNFRSF12A | tumor necrosis factor receptor superfamily, member 12A | 0.029 | ||
| PROX1 | prospero homeobox 1 | 0.028 | ||
| FOXO3 | forkhead box O3 | 0.027 | ||
| CDH2 | cadherin 2, type 1, N-cadherin (neuronal) | 0.027 | Human | |
| TCF4 | transcription factor 4 | 0.026 | ||
| EPAS1 | endothelial PAS domain protein 1 | 0.025 | ||
| PVR | poliovirus receptor | 0.025 | ||
| NR1I2 | nuclear receptor subfamily 1, group I, member 2 | 0.025 | Human | |
| MEP1A | meprin A, alpha (PABA peptide hydrolase) | 0.025 | ||
| SREBF1 | sterol regulatory element binding transcription factor 1 | 0.024 | Human | |
| MEP1B | meprin A, beta | 0.024 | ||
| PGR | progesterone receptor | 0.023 | ||
| EMD | emerin | 0.023 | ||
| APC | adenomatous polyposis coli | 0.023 | ||
| EGF | epidermal growth factor | 0.022 | ||
| VTN | vitronectin | 0.022 | ||
| PLEKHA7 | pleckstrin homology domain containing, family A member 7 | 0.022 | ||
| FRMD5 | FERM domain containing 5 | 0.022 | ||
| G6PC | glucose-6-phosphatase, catalytic subunit | 0.022 | ||
| PTAFR | platelet-activating factor receptor | 0.021 | ||
| MLLT6 | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 6 | 0.021 | ||
| VCAN | versican | 0.021 | ||
| TGFA | transforming growth factor, alpha | 0.020 | ||
| NDRG1 | N-myc downstream regulated 1 | 0.020 | ||
| HDAC3 | histone deacetylase 3 | 0.019 | ||
| ITGB4 | integrin, beta 4 | 0.019 | ||
| SPHK1 | sphingosine kinase 1 | 0.019 | ||
| ACTN1 | actinin, alpha 1 | 0.018 | ||
| ESR1 | estrogen receptor 1 | 0.017 | ||
| HTT | huntingtin | 0.017 | ||
| PTK7 | PTK7 protein tyrosine kinase 7 | 0.017 | ||
| MUC1 | mucin 1, cell surface associated | 0.017 | ||
| ABCG1 | ATP-binding cassette, sub-family G (WHITE), member 1 | 0.016 | ||
| DSG3 | desmoglein 3 | 0.016 | ||
| CDH5 | cadherin 5, type 2 (vascular endothelium) | 0.016 | ||
| PKD1 | polycystic kidney disease 1 (autosomal dominant) | 0.016 | ||
| DSG1 | desmoglein 1 | 0.016 | ||
| FOXO1 | forkhead box O1 | 0.016 | ||
| MVK | mevalonate kinase | 0.016 | ||
| MVD | mevalonate (diphospho) decarboxylase | 0.016 | ||
| SMARCD3 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3 | 0.016 | ||
| PKP2 | plakophilin 2 | 0.016 | ||
| CLCA2 | chloride channel accessory 2 | 0.015 | ||
| CITED2 | Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 | 0.015 | ||
| PTPN3 | protein tyrosine phosphatase, non-receptor type 3 | 0.015 | ||
| TAL1 | T-cell acute lymphocytic leukemia 1 | 0.015 | ||
| THBS1 | thrombospondin 1 | 0.015 | ||
| HNF1A | HNF1 homeobox A | 0.015 | ||
| ARVCF | armadillo repeat gene deleted in velocardiofacial syndrome | 0.014 | ||
| MED26 | mediator complex subunit 26 | 0.014 | ||
| GPR87 | G protein-coupled receptor 87 | 0.014 | ||
| THRB | thyroid hormone receptor, beta (erythroblastic leukemia viral (v-erb-a) oncogene homolog 2, avian) | 0.014 | ||
| VDR | vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.014 | Human | |
| NR2E3 | nuclear receptor subfamily 2, group E, member 3 | 0.014 | ||
| KRT14 | keratin 14 | 0.014 | ||
| SKIL | SKI-like oncogene | 0.014 | ||
| CDK6 | cyclin-dependent kinase 6 | 0.014 | ||
| PDK4 | pyruvate dehydrogenase kinase, isozyme 4 | 0.014 | ||
| DHCR7 | 7-dehydrocholesterol reductase | 0.014 | ||
| CCND3 | cyclin D3 | 0.014 | ||
| INHBA | inhibin, beta A | 0.013 | ||
| KNG1 | kininogen 1 | 0.013 | ||
| EMP1 | epithelial membrane protein 1 | 0.013 | ||
| DSC3 | desmocollin 3 | 0.013 | Human | |
| VAV2 | vav 2 guanine nucleotide exchange factor | 0.013 | ||
| SPP1 | secreted phosphoprotein 1 | 0.012 | ||
| ABCA12 | ATP-binding cassette, sub-family A (ABC1), member 12 | 0.012 | Human | |
| HDAC10 | histone deacetylase 10 | 0.012 | ||
| NFYC | nuclear transcription factor Y, gamma | 0.012 | ||
| MPZL2 | myelin protein zero-like 2 | 0.012 | ||
| NR0B2 | nuclear receptor subfamily 0, group B, member 2 | 0.012 | ||
| KLF13 | Kruppel-like factor 13 | 0.012 | ||
| TGFB1 | transforming growth factor, beta 1 | 0.012 | ||
| ZFYVE9 | zinc finger, FYVE domain containing 9 | 0.012 | ||
| SRCAP | Snf2-related CREBBP activator protein | 0.012 | ||
| NR1H3 | nuclear receptor subfamily 1, group H, member 3 | 0.012 | ||
| NCOA2 | nuclear receptor coactivator 2 | 0.012 | ||
| NR1I3 | nuclear receptor subfamily 1, group I, member 3 | 0.012 | Human | |
| ADH6 | alcohol dehydrogenase 6 (class V) | 0.012 | ||
| ARHGEF1 | Rho guanine nucleotide exchange factor (GEF) 1 | 0.012 | ||
| SQLE | squalene epoxidase | 0.012 | ||
| HDAC4 | histone deacetylase 4 | 0.011 | ||
| ABCG5 | ATP-binding cassette, sub-family G (WHITE), member 5 | 0.011 | ||
| CXADR | coxsackie virus and adenovirus receptor | 0.011 | ||
| HIF1A | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 0.011 | ||
| PERP | PERP, TP53 apoptosis effector | 0.011 | ||
| MED14 | mediator complex subunit 14 | 0.011 | ||
| PTK6 | PTK6 protein tyrosine kinase 6 | 0.011 | ||
| CLDN1 | claudin 1 | 0.011 | ||
| C18orf8 | chromosome 18 open reading frame 8 | 0.011 | ||
| HBEGF | heparin-binding EGF-like growth factor | 0.011 | ||
| BNC1 | basonuclin 1 | 0.011 | ||
| CDK3 | cyclin-dependent kinase 3 | 0.011 | ||
| MED25 | mediator complex subunit 25 | 0.011 | ||
| CCL18 | chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated) | 0.011 | ||
| ACTN4 | actinin, alpha 4 | 0.011 | ||
| ITGB6 | integrin, beta 6 | 0.011 | ||
| CHST11 | carbohydrate (chondroitin 4) sulfotransferase 11 | 0.011 | ||
| GPRC5A | G protein-coupled receptor, family C, group 5, member A | 0.011 | ||
| MMP12 | matrix metallopeptidase 12 (macrophage elastase) | 0.011 | ||
| ANGPTL4 | angiopoietin-like 4 | 0.011 | ||
| GJB2 | gap junction protein, beta 2, 26kDa | 0.011 | ||
| HSD17B2 | hydroxysteroid (17-beta) dehydrogenase 2 | 0.011 | ||
| PSEN1 | presenilin 1 | 0.011 | ||
| SERPINB5 | serpin peptidase inhibitor, clade B (ovalbumin), member 5 | 0.011 | ||
| SNAI1 | snail homolog 1 (Drosophila) | 0.010 | ||
| MMP1 | matrix metallopeptidase 1 (interstitial collagenase) | 0.010 | ||
| FERMT1 | fermitin family member 1 | 0.010 | ||
| BCL6 | B-cell CLL/lymphoma 6 | 0.010 | ||
| RAB11B | RAB11B, member RAS oncogene family | 0.010 | ||
| FASN | fatty acid synthase | 0.010 | ||
| CACNA1A | calcium channel, voltage-dependent, P/Q type, alpha 1A subunit | 0.010 | ||
| CYP2B6 | cytochrome P450, family 2, subfamily B, polypeptide 6 | 0.010 | ||
| TM4SF4 | transmembrane 4 L six family member 4 | 0.010 | ||
| FABP4 | fatty acid binding protein 4, adipocyte | 0.010 | ||
| ABCB11 | ATP-binding cassette, sub-family B (MDR/TAP), member 11 | 0.010 | ||
| NKD2 | naked cuticle homolog 2 (Drosophila) | 0.010 | ||
| FHL3 | four and a half LIM domains 3 | 0.010 | ||
| SLC26A3 | solute carrier family 26, member 3 | 0.010 | ||
| SULT2A1 | sulfotransferase family, cytosolic, 2A, dehydroepiandrosterone (DHEA)-preferring, member 1 | 0.010 | ||
| LEF1 | lymphoid enhancer-binding factor 1 | 0.010 |